Edwards Expands Peripheral Vascular Stent Pipeline With Orbus Deal
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences' licensing agreement with Orbus Medical Technologies marks a decisive step toward enhancing its peripheral vascular disease treatments following the divestment phase of its reorganization strategy